NOVARTIS AG's ticker is and the CUSIP is H5820Q150. A total of 2 filers reported holding NOVARTIS AG in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $49,646,056 | +2.1% | 484,084 | +0.1% | 0.11% | +8.1% |
Q2 2023 | $48,619,495 | +16.3% | 483,818 | +5.9% | 0.10% | +12.5% |
Q1 2023 | $41,789,862 | +0.0% | 456,665 | -1.1% | 0.09% | -1.1% |
Q4 2022 | $41,769,231 | +34.9% | 461,965 | +19.5% | 0.09% | +29.0% |
Q3 2022 | $30,960,000 | -3.9% | 386,465 | +5.3% | 0.07% | +1.5% |
Q2 2022 | $32,230,000 | – | 367,130 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Joel Isaacson & Co., LLC | 15,718 | $1,423,000 | 0.44% |
CHICKASAW CAPITAL MANAGEMENT LLC | 31,600 | $2,867,000 | 0.10% |
CANANDAIGUA NATIONAL BANK & TRUST CO | 2,400 | $218,000 | 0.07% |
Cullen Capital Management, LLC | 10,900 | $987,000 | 0.03% |
SILVERCREST ASSET MANAGEMENT GROUP LLC | 5,200 | $471,000 | 0.01% |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 1,390 | $126,000 | 0.00% |